News coverage about Alere (NYSE:ALR) has been trending somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Alere earned a news impact score of 0.20 on Accern’s scale. Accern also assigned news articles about the medical research company an impact score of 46.6822511079107 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
- Alere Inc. (ALR) Stock Rating Reaffirmed by Canaccord Genuity (americanbankingnews.com)
- Alere Inc. (NYSE:ALR) – Analysts’ Recommendations to Consider – The Investor Guide (wallstreetnews24.com)
- Here’s Why Quidel Corporation Stock Is Popping Today – Madison.com (host.madison.com)
- Quidel Corp (QDEL) Gains After Revised Deal on Alere’s (ALR) BNP … – StreetInsider.com (streetinsider.com)
- Alere Inc. Declares Cash Dividend on its Series B Convertible … – PR Newswire (press release) (prnewswire.com)
Several brokerages have commented on ALR. Canaccord Genuity reissued a “hold” rating and set a $51.00 price target on shares of Alere in a research report on Tuesday. BidaskClub cut shares of Alere from a “buy” rating to a “hold” rating in a research report on Sunday, July 16th. Zacks Investment Research raised shares of Alere from a “sell” rating to a “hold” rating in a research report on Tuesday, June 27th. BTIG Research reissued a “hold” rating on shares of Alere in a research report on Wednesday, May 24th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $51.00 price target on shares of Alere in a research report on Thursday, June 1st. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. Alere has an average rating of “Hold” and a consensus price target of $48.00.
Shares of Alere (ALR) opened at 50.55 on Thursday. Alere has a one year low of $34.41 and a one year high of $50.64. The company’s market capitalization is $4.43 billion. The stock has a 50 day moving average of $49.61 and a 200-day moving average of $47.44.
Alere Company Profile
Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.
Receive News & Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.